Chugai Mining
1491
Allied Telesis Holdings KK
6835
The Why How Do
3823
Booking Resort
324A
Elements
5246
JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 46
- +1+2.22%
20min DelayMarket Closed Feb 25 15:30 JST
4.05BMarket Cap-2.53P/E (Static)
46High44Low844.80KVolume46Open45Pre Close38.17MTurnover9052wk High1.01%Turnover Ratio87.95MShares4152wk Low-16.51EPS TTM3.84BFloat Cap2229Historical HighLossP/E (Static)83.40MShs Float41Historical Low-18.21EPS LYR4.44%Amplitude--Dividend TTM3.29P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Ryo Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --